Status:

COMPLETED

The Effects of Western Diet Patterns on Plasma Inflammatory and Cardio Metabolic Health Signatures in Middle-aged Adults

Lead Sponsor:

Duke University

Collaborating Sponsors:

North Dakota Beef Commission

Conditions:

Healthy Diet

Eligibility:

All Genders

35-60 years

Phase:

NA

Brief Summary

The Western diet pattern or standard American diet is a modern dietary pattern that is characterized by high intakes of meat, pre-packaged foods, fried foods, high-fat dairy products, eggs, refined gr...

Eligibility Criteria

Inclusion

  • Age ≥35 and ≤60 years;
  • BMI ≥25 and ≤35 kg/m2;
  • Weight stable in last 3 months (Loss or gain \<4%);
  • Consistent physical activity levels;
  • Hemoglobin A1C (HbA1C) ≤6.4%;
  • Fasting insulin; \<15 µU/mL;
  • Fasting plasma glucose concentration \<126 mg/dl;
  • Willingness to eat the food provided in this study;
  • Subjects must be able to speak and understand English to participate in this study
  • Own a smartphone or other mobile device capable of downloading the Garmin Connect app.

Exclusion

  • Diagnoses of active malignancy, congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, thyroid disease or other metabolic disorders that influence metabolism;
  • Evidence of impaired kidney function (Estimated glomerular filtration rate \[eGFR\] \<44 mL/min;
  • Regular use of medication that interferes with the measurement of study outcomes as determined by the study team (e.g., NSAIDs, corticosteroids);
  • Consuming \>14 drinks per week of \>4 drinks per night twice/week for male; \>7 drinks per week or \>3 drinks per night twice/week for female;
  • Use of cigarettes (or other tobacco products) or use of any other (recreational) drug in last 3 months;
  • Engaged in high-level competitive exercise (e.g., marathons, triathlons, cycling, weight-lifting competitions etc.)
  • Self-reported sleep duration \<5 hours per night;
  • Any inflammatory diseases (e.g. asthma, autoimmune diseases, coeliac disease, glomerulonephritis, hepatitis, inflammatory bowel disease, arthritis);
  • Use of antibiotics in last 30 days;
  • Pregnant or lactating women;
  • Eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorders etc.)
  • Psychological disorders (e.g., clinical depression, bipolar disorders etc.);
  • Strict dietary patterns (e.g., vegan, carnivore, kosher, low-carb etc.);
  • History of stomach or bowel resection (other than appendectomy), gastric bypass or other bariatric weight loss procedure effecting absorption;
  • Persons who are not able to grant voluntary informed consent;
  • Persons who are unable or unwilling to follow the study protocol or who, for any reason, the research team considers not an appropriate candidate for this study, including non-compliance with screening appointments or study visits.

Key Trial Info

Start Date :

October 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 21 2021

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT04275843

Start Date

October 1 2020

End Date

December 21 2021

Last Update

July 13 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University School of Medicine

Durham, North Carolina, United States, 27701